Dezhan HealthCare Co Ltd (000813) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.39 Million ≈ $-203.66K USD) by net assets (CN¥4.96 Billion ≈ $726.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000813 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Dezhan HealthCare Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Dezhan HealthCare Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Dezhan HealthCare Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dezhan HealthCare Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Oceanking Development Co Ltd
SHG:603213
|
0.065x |
|
Shanghai Hugong Elec(Group)
SHG:603131
|
0.000x |
|
KSB SE & Co. KGaA
XETRA:KSB
|
0.109x |
|
Jiangsu Changbao Steeltube Co Ltd
SHE:002478
|
0.031x |
|
LIVZON PHARMAC. GRP H YC1
F:LP6
|
N/A |
|
Shenzhen Feima International Supply Chain Co Ltd
SHE:002210
|
0.042x |
|
Sonaecom SGPS
LS:SNC
|
-0.002x |
|
SpartanNash Co
NASDAQ:SPTN
|
0.117x |
Annual Cash Flow Conversion Efficiency for Dezhan HealthCare Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Dezhan HealthCare Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Dezhan HealthCare Co Ltd (000813) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.57 Billion ≈ $669.10 Million |
CN¥4.72 Million ≈ $691.05K |
0.001x | +136.56% |
| 2024-12-31 | CN¥5.16 Billion ≈ $755.79 Million |
CN¥-14.59 Million ≈ $-2.13 Million |
-0.003x | -111.58% |
| 2023-12-31 | CN¥5.24 Billion ≈ $766.99 Million |
CN¥127.87 Million ≈ $18.71 Million |
0.024x | -20.29% |
| 2022-12-31 | CN¥5.28 Billion ≈ $773.22 Million |
CN¥161.72 Million ≈ $23.66 Million |
0.031x | +294.75% |
| 2021-12-31 | CN¥5.47 Billion ≈ $800.43 Million |
CN¥42.41 Million ≈ $6.21 Million |
0.008x | -94.42% |
| 2020-12-31 | CN¥5.95 Billion ≈ $871.12 Million |
CN¥827.54 Million ≈ $121.09 Million |
0.139x | -49.96% |
| 2019-12-31 | CN¥5.61 Billion ≈ $821.16 Million |
CN¥1.56 Billion ≈ $228.10 Million |
0.278x | +286.30% |
| 2018-12-31 | CN¥5.28 Billion ≈ $772.85 Million |
CN¥379.78 Million ≈ $55.57 Million |
0.072x | -15.02% |
| 2017-12-31 | CN¥4.55 Billion ≈ $665.14 Million |
CN¥384.64 Million ≈ $56.28 Million |
0.085x | +21.00% |
| 2016-12-31 | CN¥3.75 Billion ≈ $548.97 Million |
CN¥262.36 Million ≈ $38.39 Million |
0.070x | -23.14% |
| 2015-12-31 | CN¥1.37 Billion ≈ $200.89 Million |
CN¥124.91 Million ≈ $18.28 Million |
0.091x | -9.86% |
| 2014-12-31 | CN¥1.35 Billion ≈ $197.84 Million |
CN¥136.47 Million ≈ $19.97 Million |
0.101x | -16.57% |
| 2013-12-31 | CN¥1.41 Billion ≈ $206.33 Million |
CN¥170.59 Million ≈ $24.96 Million |
0.121x | +204.23% |
| 2012-12-31 | CN¥415.20 Million ≈ $60.76 Million |
CN¥16.51 Million ≈ $2.42 Million |
0.040x | +197.44% |
| 2011-12-31 | CN¥428.93 Million ≈ $62.77 Million |
CN¥-17.50 Million ≈ $-2.56 Million |
-0.041x | +56.93% |
| 2010-12-31 | CN¥425.26 Million ≈ $62.23 Million |
CN¥-40.29 Million ≈ $-5.90 Million |
-0.095x | -211.41% |
| 2009-12-31 | CN¥423.61 Million ≈ $61.99 Million |
CN¥36.03 Million ≈ $5.27 Million |
0.085x | -27.99% |
| 2008-12-31 | CN¥478.64 Million ≈ $70.04 Million |
CN¥56.53 Million ≈ $8.27 Million |
0.118x | +906.90% |
| 2007-12-31 | CN¥470.05 Million ≈ $68.78 Million |
CN¥-6.88 Million ≈ $-1.01 Million |
-0.015x | -129.17% |
| 2006-12-31 | CN¥450.91 Million ≈ $65.98 Million |
CN¥22.62 Million ≈ $3.31 Million |
0.050x | -87.82% |
| 2005-12-31 | CN¥327.22 Million ≈ $47.88 Million |
CN¥134.83 Million ≈ $19.73 Million |
0.412x | +172.81% |
| 2004-12-31 | CN¥296.13 Million ≈ $43.33 Million |
CN¥44.73 Million ≈ $6.55 Million |
0.151x | +1313.82% |
| 2003-12-31 | CN¥472.51 Million ≈ $69.14 Million |
CN¥-5.88 Million ≈ $-860.37K |
-0.012x | -126.33% |
| 2002-12-31 | CN¥676.78 Million ≈ $99.03 Million |
CN¥31.98 Million ≈ $4.68 Million |
0.047x | +145.23% |
| 2001-12-31 | CN¥650.49 Million ≈ $95.19 Million |
CN¥-67.96 Million ≈ $-9.95 Million |
-0.104x | -65.03% |
| 2000-12-31 | CN¥650.09 Million ≈ $95.13 Million |
CN¥-41.16 Million ≈ $-6.02 Million |
-0.063x | -176.18% |
| 1999-12-31 | CN¥639.51 Million ≈ $93.58 Million |
CN¥53.15 Million ≈ $7.78 Million |
0.083x | -49.57% |
| 1998-12-31 | CN¥612.87 Million ≈ $89.68 Million |
CN¥101.00 Million ≈ $14.78 Million |
0.165x | -- |
About Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathi… Read more